Prenatal Exposure to Paracetamol Impairs Masculinization
By HospiMedica International staff writers Posted on 05 Jul 2017 |
A new study suggests that paracetamol/acetaminophen (N-Acetyl-p-Aminophenol; APAP) can inhibit androgens and prostaglandin action during fetal development, resulting in reduced sex drive and impaired male aggressive behavior.
Researchers at the University of Copenhagen (KU, Denmark), the French National Institute of Health and Medical Research (INSERM; Strasbourg, France), and other institutions conducted intrauterine APAP exposure experiments in C57BL/6 mice, who were administered a dosage very close to the recommended dosage for pregnant women. The researchers found that exposure to APAP decreased neuronal number in the sexually dimorphic nucleus (SDN) of the preoptic area (POA) in the anterior hypothalamus of male adult offspring.
Likewise, exposure to the environmental pollutant and precursor of APAP, aniline, resulted in a similar reduction in neuronal number in the SDN-POA, the brain area associated with reductions in male sexual behavior. Consistent with the changes, male mice exposed in uteri to APAP exhibited changes in urinary marking behavior as adults, and had a less aggressive territorial display towards intruders of the same gender. The exposed males also had reduced intromissions and ejaculations during mating. The study was published on May 30, 2017, in Reproduction.
“We have demonstrated that a reduced level of testosterone means that male characteristics do not develop as they should; this also affects sex drive,” said senior author David Møbjerg Kristensen, PhD, of the KU department of biomedical sciences. “Mice exposed to paracetamol at the fetal stage were simply unable to copulate in the same way as our control animals. Male programming had not been properly established during their fetal development, and this could be seen long afterwards in their adult life. It is very worrying.”
Paracetamol, discovered in 1877, is classified as a mild analgesic, commonly used for the relief of headaches and other minor aches and pains, and is a major ingredient in numerous cold and flu remedies. APAP use during pregnancy has previously been associated with increased risk of childhood asthma and ADHD, but it is unclear whether the relationship is causal.
Related Links:
University of Copenhagen
French National Institute of Health and Medical Research
Researchers at the University of Copenhagen (KU, Denmark), the French National Institute of Health and Medical Research (INSERM; Strasbourg, France), and other institutions conducted intrauterine APAP exposure experiments in C57BL/6 mice, who were administered a dosage very close to the recommended dosage for pregnant women. The researchers found that exposure to APAP decreased neuronal number in the sexually dimorphic nucleus (SDN) of the preoptic area (POA) in the anterior hypothalamus of male adult offspring.
Likewise, exposure to the environmental pollutant and precursor of APAP, aniline, resulted in a similar reduction in neuronal number in the SDN-POA, the brain area associated with reductions in male sexual behavior. Consistent with the changes, male mice exposed in uteri to APAP exhibited changes in urinary marking behavior as adults, and had a less aggressive territorial display towards intruders of the same gender. The exposed males also had reduced intromissions and ejaculations during mating. The study was published on May 30, 2017, in Reproduction.
“We have demonstrated that a reduced level of testosterone means that male characteristics do not develop as they should; this also affects sex drive,” said senior author David Møbjerg Kristensen, PhD, of the KU department of biomedical sciences. “Mice exposed to paracetamol at the fetal stage were simply unable to copulate in the same way as our control animals. Male programming had not been properly established during their fetal development, and this could be seen long afterwards in their adult life. It is very worrying.”
Paracetamol, discovered in 1877, is classified as a mild analgesic, commonly used for the relief of headaches and other minor aches and pains, and is a major ingredient in numerous cold and flu remedies. APAP use during pregnancy has previously been associated with increased risk of childhood asthma and ADHD, but it is unclear whether the relationship is causal.
Related Links:
University of Copenhagen
French National Institute of Health and Medical Research
Latest Patient Care News
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
- World's First AI-Ready Infrasound Stethoscope Listens to Bodily Sounds Not Audible to Human Ear